Dernières nouvelles pour Galapagos (NASDAQ:GLPG) Stock

Galapagos

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Galapagos NV - American Depositary Shares

Galapagos NV

News

Offerings

PNBK

Patriot National Bancorp Files For Mixed Shelf Offering Up To $250M

Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) has outperformed the market over the past 5 years by 26.92% on an annualized basis producing an average annual return of 41.93%. Currently, Fair Isaac has a market capitalization of $51.75 billion. 
Buying $1000 In FICO: If an investor had bought $1000 of FICO stock 5 years ago, it would be worth $5,797.86 today based on a price of $2125.90 for FICO at the time of writing.
<h3>Fair Isaac's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747258221_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

FICO

Here's How Much $1000 Invested In Fair Isaac 5 Years Ago Would Be Worth Today

Stantec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STN#NYSE">STN</a>) lowers FY2025 Adj EPS guidance from $3.67-$3.76 to $3.57-$3.67 vs $5.23 analyst estimate. Lowers FY2025 sales outlook from $4.49 billion-$4.61 billion to $4.37 billion-$4.50 billion vs $6.50 billion estimate.

Guidance

Stantec Lowers FY2025 Adj EPS Guidance from $3.67-$3.76 to $3.57-$3.67 vs $5.23 Est; Lowers FY2025 Sales Guidance from $4.49B-$4.61B to $4.37B-$4.50B vs $6.50B Est

Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) reported quarterly losses of $(1.28) per share which beat the analyst consensus estimate of $(1.40) by 8.57 percent. This is a 67.92 percent increase over losses of $(3.99) per share from the same period last year. The company reported quarterly sales of $2.92 million which beat the analyst consensus estimate of $2.49 million by 17.35 percent. This is a 29.41 percent increase over sales of $2.25 million the same period last year.

Earnings

Earnings Beats

KSCP

Knightscope Q1 EPS $(1.28) Beats $(1.40) Estimate, Sales $2.92M Beat $2.49M Estimate

California Water Service Group Files For Common Stock Offering Of Up To $350M

Natural Alternatives Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAII#NASDAQ">NAII</a>) reported quarterly losses of $(0.37) per share. This is a 37.04 percent decrease over losses of $(0.27) per share from the same period last year. The company reported $28.77 million in sales this quarter. This is a 14.44 percent increase over sales of $25.14 million the same period last year.

NAII

Natural Alternatives Intl Q3 EPS $(0.37) Down From $(0.27) YoY, Sales $28.77M Up From $25.14M YoY

Stantec (TSX:<a class="ticker" href="https://www.benzinga.com/stock/STN#TSX">STN</a>) affirms FY2025 Adj EPS guidance from $5.13-$5.26 to $5.13-$5.26 vs $5.24 analyst estimate. Affirms FY2025 sales outlook from $6.28 billion-$6.45 billion to $6.28 billion-$6.45 billion vs $6.53 billion estimate.

TSX:STN

Stantec Affirms FY2025 Adj EPS Guidance of $5.13-$5.26 vs $5.24 Est; Affirms FY2025 Sales Guidance of $6.28B-$6.45B vs $6.53B Est

Management

LAZR

Luminar Technologies Appoints Paul Ricci As CEO, Effective On Or About May 21, 2025

WIIM

GCTS

GCTS stock has given up its prior loss. GCT Semiconductor shares were trading lower after the company reported worse-than-expected Q1 financial results.

Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) released its first-quarter results after Wednesday's closing bell. Here's a look at the key figures from the quarter. 
The Details:  Luminar Technologies reported quarterly losses of $1.50 per share, which beat the analyst consensus estimate of losses of $1.78. Quarterly revenue came in at $18.89 million, which beat the Street estimate of $15.98 million.
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/05/45414265/nvidia-climbs-on-saudi-ai-investments-analyst-estimates-15-billion-to-20-billion-in-revenue?utm_source=articleShare">Nvidia Climbs On Saudi AI Investments: Analyst Estimates $15 Billion To $20 Billion In Revenue&nbsp;</a>
Luminar announced a new operating plan enabled by a unified product architecture. The company expects it will reduce quarterly non-GAAP opreational expenditures by approximately half by the end of fiscal 2025 versus the beginning of fiscal 2024.
&#8220;In a world of macro uncertainty and adversity, we&#8217;re firing on all cylinders to ramp up production, ramp down costs and capitalize on the future, as evidenced by our announcements today,&#8221; said CEO Austin Russell.
&#8220;This kicks off our new operating plan for Luminar with a unified product platform, enabling radical focus and streamlining of the business, as well as unlocking value throughout our organization.&#8221;
LAZR Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Luminar Technologies stock was down 1.68% at $4.68 after-hours on Wednesday.  
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45353123/quantum-stocks-are-hot-in-2025-biggest-movers-to-watch?utm_source=articleShare">Quantum Stocks Are Hot In 2025: Biggest Movers To Watch&nbsp;</a></li>
</ul>
Image: Shutterstock

Movers

Tech

Luminar Technologies Shares Slip After Q1 Results, New Operating Plan

Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million vs $33.43 million estimate.

BNGO

Bionano Genomics Lowers FY2025 Sales Guidance from $29.00M-$32.00M to $26.00M-$30.00M vs $33.43M Est

Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) sees Q2 sales of $6.300 million-$6.800 million vs $7.02 million analyst estimate.

Bionano Genomics Sees Q2 Sales $6.300M-$6.800M vs $7.02M Est

Dick's Sporting Goods shares are trading lower after WSJ reported the company is near a deal to buy Foot Locker.

Foot Locker shares are trading higher after WSJ reported Dick's Sporting Goods nears deal to buy the company.

<a href="https://www.wsj.com/business/deals/dicks-sporting-goods-nears-deal-to-buy-foot-locker-7ecf9194?msockid=21c662101c496b42343370ae1de86aaa">https://www.wsj.com/business/deals/dicks-sporting-goods-nears-deal-to-buy-foot-locker-7ecf9194?msockid=21c662101c496b42343370ae1de86aaa</a>

General

'Dick's Sporting Goods Nears Deal to Buy Foot Locker'- Wall Street Journal

Acquisition Adds Patented Water Treatment Technology with Expected Broad Cross- Platform Applications; Increases Shareholder Equity Through Preferred Stock Structure
Transaction Strengthens Edible Garden's Balance Sheet with $3 Million of Cash Through Private Placement
Intended to Enhance Vertically Integrated Model and Advance Zero-Waste Inspired&#xAE; Mission in High-Growth, Sustainable Agriculture Sector
Strengthens Edible Garden's Leadership in Sustainability and Controlled Environment Agriculture
BELVIDERE, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced the acquisition of certain assets of a sustainable aquaculture company based in Fort Dodge, Iowa, from NaturalShrimp Farms Inc. ("NaturalShrimp"). Edible Garden purchased the NaturalShrimp assets in exchange for $12 million of a new class of the Company's preferred stock. In addition, an affiliate of NaturalShrimp, agreed to purchase $3.5 million of the Company's preferred stock for cash, of which $3 million is being funded immediately, bringing its total investment in the Company's preferred stock to $15.5 million. As part of the acquisition, Edible Garden will gain two innovative patents for environmentally friendly water treatment technologies, along with a fully operational shrimp farming facility.
The acquisition is expected to support multiple strategic initiatives at Edible Garden, including expanded R&amp;D and warehousing. The Company intends to integrate the patented water treatment technology across its existing CEA operations, opening new possibilities for improving agricultural efficiency and sustainability. This development aligns with Edible Garden's Zero-Waste Inspired&#xAE; mission and enhances the Company's vertically integrated model.

EDBL

Edible Garden Acquires Patented Water Treatment Technology And Operational Shrimp Facility From NaturalShrimp In $15.5M Preferred Stock Deal, Adding $3M In Cash, Enhancing Balance Sheet, Advancing Zero-Waste Inspired Mission, And Expanding Cross-Platform Applications In Sustainable Agriculture

Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.08 by 62.5 percent. This is a 137.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported $57.02 million in sales this quarter.

Earnings Misses

ITRG

Integra Resources Q1 Adj. EPS $0.03 Misses $0.08 Estimate, Sales $57.02M

IPDN

Professional Diversity Q1 EPS $(0.39) Up From $(0.70) YoY, Sales $1.50M Down From $1.73M YoY

Sadot Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDOT#NASDAQ">SDOT</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.20 by 20 percent. This is a 20 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $132.17 million which missed the analyst consensus estimate of $145.70 million by 9.29 percent. This is a 24.09 percent increase over sales of $106.51 million the same period last year.

SDOT

Sadot Group Q1 EPS $0.16 Misses $0.20 Estimate, Sales $132.17M Miss $145.70M Estimate

Tungray Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) reported quarterly losses of $(0.03) per share. This is a 150 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $12.81 million in sales this quarter. This is a 10.81 percent decrease over sales of $14.36 million the same period last year.

TRSG

Tungray Technologies FY EPS $(0.03) Down From $0.06 YoY, Sales $12.81M Down From $14.36M YoY

Press Releases

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

Galapagos receives transparency notification and 13D filing from Tang Capital

Galapagos to Present at Upcoming Investor Conferences

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders' Meeting

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

Galapagos Announces Executive Leadership Updates

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

Comments

Galapagos

Actualités

Dernières nouvelles pour Galapagos (NASDAQ:GLPG) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL